Sam is an experienced Chief Executive Officer and Chairman with a demonstrated history of working in the medical technologies and commercialisation in high growth companies. Working across a range of industrial applications including pharmaceuticals, medical devices, diagnostics, and life sciences. Sam is currently the Executive chairman of High Force Research, a small molecule CDMO and the CEO of LightOx Ltd,developing light activated targeted therapies for Oral cancer and wound care treatments. Sam is a also a Royal Society Entrepreneur in Residence, and a Fellow of the Royal Society of Chemistry.
Listed skills include Biotechnology, R&D, Technology Transfer, Life Sciences, and 22 others.